miRNA	gene	miRNA_log2FC	miRNA_pvalue	gene_log2FC	gene_pvalue	interactions	correlation_beta	correlation_pvalue	PMID	evidence	outcome	cancer
hsa-miR-21-5p	TET1	2.32007501846389	3.08394781855554e-137	-0.560839118524932	2.47023070053678e-06	miRNAWalker2_validate	-0.219366694016521	3.08336716646783e-09		NA	NA	NA
hsa-miR-29a-3p	TET1	-0.699539666833076	1.13935003139957e-13	-0.560839118524932	2.47023070053678e-06	miRNAWalker2_validate;miRTarBase;MirTarget;miRNATAP	-0.121055322616723	0.00497623456890235	27555295;25367851;25616722	Furthermore data from bioinformatic analysis validated by dual-luciferase reporter gene assay showed that ten eleven translocation 1 TET1 was a direct target of miR-29a and over-expression of TET1 inhibited cell proliferation and migration which could be induced by the up-regulation of miR-29a; MiR-29a targets TET1 down regulates its expression and thus promotes EMT in breast cancer; Altogether we demonstrate that miR-29a acts as a tumor activator by targeting TET1 and induces cell proliferation and EMT in breast cancer;Negative feedback of miR 29 family TET1 involves in hepatocellular cancer; MiR-29b was proved to inhibit metastasis through the targeting of TET1 indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression;Erratum to: Negative feedback of miR 29 family TET1 involves in hepatocellular cancer; miR-29b was proved to inhibit metastasis through the targeting of TET1 indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression	;metastasis;progression;tumorigenesis;metastasis;progression;tumorigenesis	breast cancer;liver cancer;liver cancer
hsa-miR-29b-3p	TET1	0.438847962603729	6.46722433236121e-05	-0.560839118524932	2.47023070053678e-06	miRNAWalker2_validate;miRTarBase;MirTarget;miRNATAP	-0.16104208480761	1.50396462937635e-05	25367851;25616722	Negative feedback of miR 29 family TET1 involves in hepatocellular cancer; MiR-29b was proved to inhibit metastasis through the targeting of TET1 indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression;Erratum to: Negative feedback of miR 29 family TET1 involves in hepatocellular cancer; miR-29b was proved to inhibit metastasis through the targeting of TET1 indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression	metastasis;progression;tumorigenesis;metastasis;progression;tumorigenesis	liver cancer;liver cancer
hsa-miR-29c-3p	TET1	-0.0652732378039769	0.563774115756922	-0.560839118524932	2.47023070053678e-06	MirTarget;miRNATAP	-0.411917359075481	7.16963817256472e-32		NA	NA	NA
hsa-miR-342-3p	TET1	1.21944481975657	6.81914373001202e-19	-0.560839118524932	2.47023070053678e-06	miRanda	-0.1159129829026	7.11329052918399e-05		NA	NA	NA